Friday June 23rd 2017

Archive for June, 2016

Tracking brain atrophy in MS could become routine, thanks to new software

Tracking brain atrophy in MS could become routine, thanks to new software

The loss of brain tissue, called brain atrophy, is a normal part of aging, but multiple sclerosis (MS) accelerates the process. Such atrophy is a critical indicator of physical and cognitive decline in MS, yet because measuring brain atrophy is expensive and complicated, [Read More]

Phyzit of Little Rock Announces Partnership With CareSync

Phyzit of Little Rock Announces Partnership With CareSync

Transitional Care Management software vendor Phyzit of Little Rock and chronic care management vendor CareSync of Tampa, Florida, announced Thursday a partnership they said will bring providers tools to make it easier to meet requirements for Medicare reimbursement. The [Read More]

Burden on patients: Insurance benefit design ’s impact on patient access to medicines

Burden on patients: Insurance benefit design ’s impact on patient access to medicines

< div class="hs-featured-image-wrapper" > < a href="http://catalyst.phrma.org/burden-on-patients-insurance-benefit-designs-impact-on-patient-access-to-medicines" title="" class="hs-featured-image-link" > < img [Read More]

 Page 1 of 41  1  2  3  4  5 » ...  Last » 

Latest Topics

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill

MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Type I interferons could have role in natural improvement of RA during pregnancy

Type I interferons could have role in natural improvement of RA during pregnancy

An international US-Danish team of scientists, led by Damini Jawaheer, Ph.D. at the UCSF Benioff Children's Hospital [Read More]

Shared decision-making essential to optimal treatment and quality of life for patients with MS

Shared decision-making essential to optimal treatment and quality of life for patients with MS

One of the cornerstones of multiple sclerosis treatment is shared decision-making between patients and their doctors [Read More]

UC consortium formed to speed up development of new drugs

UC consortium formed to speed up development of new drugs

For 12 years, UCLA researcher Dennis Slamon pursued a groundbreaking approach to treating breast cancer: Attack the [Read More]